Contracts
Framework
NEYPPC Pharmacy - Unlicensed Imported Medicines (wave 2)
The North East and Yorkshire NHS Pharmaceutical Purchasing Consortium is establishing a framework agreement for the supply of unlicensed imported medicines to NHS organisations. Suppliers must hold MHRA licences and approvals to import, distribute and supply these medicines in compliance with GMP and GDP standards.
- Closes30 November 2026, 12 noon
- Published13 October 2026
- Value£36m
- BuyerLeeds Teaching Hospitals NHS Trust
- CategoryHealth & medical
- RegionNorth East, Yorkshire & Humber
You'll want to look if you hold MHRA authorisations for importing unlicensed medicines and can demonstrate GMP and GDP compliance
You'll need
- MHRA licences and approvals to import and distribute unlicensed medicines
- Compliance with Good Manufacturing Practice (GMP) standards
- Compliance with Good Distribution Practice (GDP) standards
- Regulation 167 Human Medicines Regulations 2012 compliance
Might not suit a small firm
- the contract itself is a large one
Possible incumbent
Alliance Healthcare, AAH Pharmaceuticals Limited and Phoenix Healthcare won the most recent licensed medicines supply contract for the consortium in October 2026. Inferred from prior awards to this buyer, not confirmed.